Dr. Emad Eskandar is a Neurosurgeon at the Massachusetts General Hospital and an Associate Professor at Harvard Medical School. He specializes in the treatment of Epilepsy, Movement Disorders, Trigeminal Neuralgia, along with Brain and Spine Tumors
Dr. Emad Eskandar is a Neurosurgeon at the Massachusetts General Hospital (MGH) and a Professor of Surgery at Harvard Medical School. He obtained his MD at the University of Southern California, and completed his residency training at MGH and Harvard. He is the Director of Functional Neurosurgery and Residency Director at MGH.
Dr. Eskandar leads an active multidisciplinary program and collaborates closely with colleagues in Psychiatry, Neurology and Anesthesia. He specializes in employing cutting-edge surgical treatments for Movement Disorders, Epilepsy, Pain, and severe Psychiatric Disorders. For example, Dr. Eskandar is currently employing, or investigating, the role of deep brain stimulation (DBS) in the treatment of Pediatric Dystonia, Parkinson Disease, and Major Depression. In addition, Dr. Eskandar is involved in studying the role of implanted stimulators to treat epilepsy and stroke.
Dr. Eskandar heads an active basic research laboratory investigating the Basal Ganglia, a group of centrally located nuclei in the brain. The Basal Ganglia play a central role in learning, motivation, depression and drug addiction. His group uses microelectrode recordings and deep brain stimulation to evaluate the role of the basal ganglia in performing complex behavioral tasks. This is a unique approach in that ideas from the laboratory can quickly be tested in the clinical arena and vice-versa.
Dr. Eskandar has been the recipient of numerous honors and awards including the Grass Neuroscience Fellowship and the Excellence in Teaching Award from Harvard Medical School. He was awarded the Howard Hughes Medical Institute Physician Scientist Early Career Award. In addition Dr. Eskandar has funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF).
Anita Levy, 59, arrived at Massachusetts General Hospital in 2012 with severe heart failure. The mother of four, grandmother of eight and wife of 38 years, was starting to lose hope. After trying a number of therapies without success, her doctors informed her she was a candidate for a new clinical trial.
Advances in pre-surgical evaluation methods have made it possible to more accurately identify the epileptogenic region and minimize risk of injury to the functional cortex, enabling more epilepsy patients to receive surgical treatment.
NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.
A study from MGH researchers finds that a structure deep within the brain, believed to play an important role in regulating conscious control of goal-directed behavior, helps to optimize responses to changing conditions by predicting how difficult upcoming tasks will be.
New research initiative is designed to treat PTSD TBI, and other neurological and psychiatric disorders.
New technology developed at the Martinos Center for Biomedical Imaging at MGH may extend the benefits of magnetic resonance imaging to many patients whose access to MRI is currently limited.